Select the doctor you prefer and book a visit with him or her in a matter of minutes.
MEDICAL NEWS
On November 14, 2019, the Food and Drug Administration granted accelerated approval to zanubrutinib (BRUKINSA, BeiGene, Ltd.) for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. Efficacy was evaluated in BGB-3111-206 (NCT03206970), a phase 2 open-label, multicenter, single-arm trial of 86 patients with MCL who received at least
Read More
On November 8, 2019, the Food and Drug Administration approved luspatercept-aamt (REBLOZYL, Celgene Corp.) for treatment of anemia in adult patients with beta thalassemia who require regular red blood cell transfusions. Efficacy was evaluated in the BELIEVE trial (NCT02604433), a multicenter, randomized, double-blind, placebo-controlled trial enrolling 336 adult patients with beta thalassemia requiring regular red
Read More
On August 16, 2018, the Food and Drug Administration granted accelerated approval to nivolumab (Opdivo, Bristol-Myers Squibb Company Inc.) for patients with metastatic small cell lung cancer (SCLC) with progression after platinum-based chemotherapy and at least one other line of therapy. Approval was based on demonstration of a durable overall response rate (ORR) in a
Read More
PATIENT TESTIMONIALS
What do our patient say?
Our family can not say enough about Dr Jawed, Bill and his staff. They are the most courteous and a very pleasant group. They go out of their way to accommodate you and make sure that whatever is needed is taken care of. There is a hope where all is lost. We thank God everyday for them being introduced into our mother life and treatment.
The Richardson family.
CONTACT DETAILS
PASADENA CLINIC
4102 Woodlawn Ave Suite 160
Pasadena – TX – 77504
CLEARLAKE / SOUTH EAST HOUSTON
11914 Astoria Suite 480
Houston, TX 77089
+(832) 879-2942
info@houstonctc.meshbeta.com
Who are we
